Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
1.040
+0.010 (0.97%)
At close: Dec 18, 2025, 4:00 PM EST
1.030
-0.010 (-0.96%)
After-hours: Dec 18, 2025, 7:49 PM EST
Aptevo Therapeutics Market Cap
Aptevo Therapeutics has a market cap or net worth of $17.52 million as of December 18, 2025. Its market cap has increased by 298.28% in one year.
Market Cap
17.52M
Enterprise Value
1.25M
1-Year Change
298.28%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since July 20, 2016, Aptevo Therapeutics's market cap has decreased from $160.50M to $17.52M, a decrease of -89.08%. That is a compound annual growth rate of -20.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 17.40M | 690.91% |
| Dec 31, 2024 | 2.20M | -31.25% |
| Dec 29, 2023 | 3.20M | -72.88% |
| Dec 30, 2022 | 11.80M | -69.27% |
| Dec 31, 2021 | 38.40M | -74.67% |
| Dec 31, 2020 | 151.60M | 413.90% |
| Dec 31, 2019 | 29.50M | 2.08% |
| Dec 31, 2018 | 28.90M | -68.17% |
| Dec 29, 2017 | 90.80M | 85.69% |
| Dec 30, 2016 | 48.90M | -69.53% |
| Jul 20, 2016 | 160.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 931.64B |
| Johnson & Johnson | 506.05B |
| AbbVie | 394.41B |
| UnitedHealth Group | 304.71B |
| AstraZeneca | 282.48B |
| Novartis AG | 258.61B |
| Merck & Co. | 243.06B |
| Novo Nordisk | 221.32B |